COMMUNIQUÉS West-GlobeNewswire

San Diego-based Park Mental Health Treatment Facility Highlights Importance of Mental Wellness Recognized as Year-Round Healthcare Priority
17/09/2026
Mental Wellness Requires Preventive Approach, Too San Diego, CA., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Each year, specific months are dedicated to bringing awareness to various mental health topics; depression, PTSD, [...]
San Diego-based Shoreline Recovery Center Encourages Compassionate Support for those Struggling with Addiction
17/09/2026
From Overdose Awareness to Recovery San Diego, CA., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Overdose is a common and serious risk for individuals with a substance use disorder. It is also preventable, with the simple act of [...]
Live Oaks Wellness Addiction Treatment Facility Strengthens Marin County Recovery Community through Outreach, Education and Service
17/09/2026
Recent ‘Recover or Die’ Charity Event Raises Awareness for Substance Addiction NOVATO, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- When it comes to increasing responsible conversation around addiction and reducing the [...]
Novo: CHMP recommends EU approval of FREHEMGO® (denecimig), the first factor VIIIa mimetic offering monthly, once every two weeks and weekly dosing in a pre-filled pen, for the treatment of haemophilia A
17/09/2026
FREHEMGO® (denecimig) has been recommended by CHMP for approval in the EU for the treatment of haemophilia A (congenital FVIII deficiency), with or without inhibitors for adults and children FREHEMGO® is the first [...]
Universal Door Meditation Center establishes Thai Pho Mon Awakened Center
17/09/2026
Thai Theravada monk Ajahn Marut donated his ancestral family land in Surat Thani province to the Sugar Land, Texas, organization, 25 years after its founder completed her awakening in Thailand Awakened Zen Master Thich [...]
FemPulse Ring Gains CE Mark Certification for the EU
17/09/2026
VIENNA and SAN FRANCISCO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- FemPulse™, a bioelectronic medical technology company with first application overactive bladder (OAB), announced today that the Company’s FemPulse Ring™ has [...]
VIRBAC: Une marge opérationnelle2 solide de 18,8 %, portée par une croissance soutenue du chiffre d'affaires de +7,4 %
17/09/2026
Le premier semestre 2026 affiche une solide croissance du chiffre d'affaires de +7,4 % et une marge d'EBIT ajusté² de 18,8 % à PCC¹ : La croissance du chiffre d'affaires provient des deux segments : animaux de compagnie [...]
VIRBAC: A robust adjusted EBIT margin² of 18.8%, driven by solid organic revenue growth of 7.4%
17/09/2026
H1 2026 delivered a robust revenue growth of +7.4% and an adjusted EBIT margin 2 of 18.8% at CERS: Revenue growth is coming from both segments : companion animal +10.0% and farm animal +6.7% with a strong contribution [...]
PracticeLink Opens Fall 2026 First Practice Fund Applications
17/09/2026
$2,500 awards support aspiring physicians and advanced practice providers on their journey from training to practice ST. LOUIS and HINTON, West Virginia, Sept. 17, 2026 (GLOBE NEWSWIRE) -- PracticeLink today announced [...]
Clearmind Medicine Delivers Briefing to FDA Following Invitation to Historic Psychedelic Hearing in Washington, D.C.
17/09/2026
Mary-Elizabeth Gifford, Chief of Global Impact at Clearmind Medicine, spoke on patient access and shared insights from Clearmind’s clinical trial at Yale and Johns Hopkins Vancouver, Canada, Sept. 17, 2026 (GLOBE [...]
Applied Biologics Receives Service-Disabled Veteran-Owned Small Business Certification
17/09/2026
Federal certification recognizes veteran ownership and strengthens Company’s ability to expand partnerships across federal healthcare and government markets SCOTTSDALE, Ariz., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Applied [...]
Firefly Neuroscience’s Evoke™ Platform Selected to Bring Objective Brain-Function Insights to Radial’s AI-Native Operating System for Brain Medicine
17/09/2026
– This integration of Firefly’s FDA 510(k)-cleared, AI-powered EEG/ERP technology follows Radial’s August 2026 acquisition of the management services organization supporting Mindful Health Solutions, forming the country [...]
Adaptive Biotechnologies Announces Update to NCCN Guidelines® for Multiple Myeloma, Strengthening MRD Testing Recommendations and Specifically Referencing clonoSEQ®
17/09/2026
Updated guidelines establish a dedicated framework for routine MRD assessment across the multiple myeloma patient journey clonoSEQ named as an FDA-cleared assay for MRD assessment, with 10 -6 sensitivity now preferred [...]
Catheter Precision Expands LockeT Commercialization Across Latin America Following Successful Launch in Brazil
17/09/2026
LockeT Has Expanded to Six Hospitals in Brazil Since Its August Launch Company Engages Experienced Cardiology Group to Support Expansion Across Argentina, Chile, Colombia and Additional Latin American Markets FORT MILL [...]
Artiva Biotherapeutics to Participate in the Stifel 2026 Virtual Immunology and Inflammation Forum
17/09/2026
SAN DIEGO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV) (Artiva), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for [...]
Quince Therapeutics to Host Virtual KOL Event to Discuss the Current Treatment Landscape for PH-ILD and BOS and the Role for LAM-001 as a Potential Therapeutic Option on September 28, 2026
17/09/2026
SOUTH SAN FRANCISCO, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for [...]
Hemab Therapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of HMB-003, an Investigational Therapy for the Management of Heavy Menstrual Bleeding
17/09/2026
Heavy menstrual bleeding is reported in approximately 1 in 3 reproductive-aged women, according to the American College of Obstetricians and Gynecologists, with approximately 23 million seeking care from a healthcare [...]
Matisse Pharmaceuticals closed Series A financing round to advance isupartob sodium through phase 2 clinical development
17/09/2026
Geleen, September 17, 2026 Matisse Pharmaceuticals B.V., a clinical stage company developing isupartob sodium for the treatment of sepsis, today announced the successful completion of its Series A financing round. The € [...]
Aerska Appoints Laura Sepp-Lorenzino to Scientific Advisory Board
17/09/2026
Appointment supports Aerska's progression of its antibody-oligo conjugate platform and growing pipeline of RNA therapeutics for CNS disease Laura brings decades of leadership in developing complex genetic medicines from [...]

Pages